Patent Assignment
Reel/Frame 049911/0881
Change of Name
Recorded: 2019-07-30
Pages: 8
Assignor
AERPIO THERAPEUTICS, INC.
Executed: 2017-03-15
Assignee
AERPIO THERAPEUTICS LLC
9987 CARVER ROAD, CINCINNATI, OHIO, 45242
Covered Properties
(3)
Methods of Treating Diabetic Nephropathy Using Hptpb Inhibitors
Application:
16/284,349 →
Publication:
US 2019/0262321
Methods of Treating Diabetic Nephropathy Using Hptpb Inhibitors
Application:
62/635,102 →
Methods of Treating Diabetic Nephropathy Using Hptpb Inhibitors
Application:
62/790,646 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 13, 2018
From: PETERS, KEVIN; PAKOLA, STEPHEN; BRIGELL, MITCHELL
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 045945/0593 →
Assignment of Assignor's Interest
Jan 16, 2019
From: SHALWITZ, ROBERT
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 048021/0464 →
Assignment of Assignor's Interest
Jan 24, 2019
From: PETERS, KEVIN; BRIGELL, MITCHELL; PAKOLA, STEPHEN; SHALWITZ, ROBERT
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 048125/0913 →
Assignment of Assignor's Interest
Feb 26, 2019
From: PETERS, KEVIN; BRIGELL, MITCHELL; PAKOLA, STEPHEN; SHALWITZ, ROBERT
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 048443/0929 →
Assignment of Assignor's Interest
Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest
Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →